A genetic mechanism for Tibetan high-altitude adaptationFelipe Lorenzo, Josef T. Prchal, Tatum S. Simonson et al.|Nature Genetics|2014Cited by 441
Nuclear–Cytoplasmic Transport Is a Therapeutic Target in MyelofibrosisDongqing Yan, Michael W. Deininger, Anthony D. Pomicter et al.|Clinical Cancer Research|2018Cited by 40
Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responsesTsewang Tashi, Josef T. Prchal, Sabina Świerczek et al.|Leukemia|2018Cited by 21
Plasma quantitation of JAK2 mutation is not suitable as a clinical test: an artifact of storageMohamed E. Salama, Josef T. Prchal, Sabina Świerczek et al.|Blood|2009Cited by 11
Calreticulin mutated prefibrotic-stage myelofibrosis and PMF represent an independent clone from coexisting CLLMohamed E. Salama, Josef T. Prchal, Sabina Świerczek et al.|Blood|2014Cited by 7